Guillaume Roquin - Publications

Clinical and Pathological Features of EC-cell Familial Small Intestine Neuroendocrine Tumors: A Nationwide Cohort From the French GTE-RENATEN Network.

Journal: Endocrine pathology

Published: November 17, 2025

Clinical description and development of a prognostic score for neurofibromatosis type 1 (NF1)-associated GISTs: a retrospective study from the NETSARC.

Journal: ESMO open

Published: September 05, 2024

Oral vitamin B12 supplementation in pernicious anemia: a prospective cohort study.

Journal: The American journal of clinical nutrition

Published: January 10, 2024

Further decompensation in cirrhosis: Results of a large multicenter cohort study supporting Baveno VII statements.

Journal: Hepatology (Baltimore, Md.)

Published: May 31, 2023

Bevacizumab plus FOLFIRI after failure of platinum-etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial.

Journal: The Lancet. Oncology

Published: November 22, 2022

Metastatic colorectal carcinoma with signet-ring cells: Clinical, histological and molecular description from an Association des Gastro-Entérologues Oncologues (AGEO) French multicenter retrospective cohort.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: May 24, 2021

Plasmatic and Urinary 5-Hydroxyindolacetic Acid Measurements in Patients With Midgut Neuroendocrine Tumors: A GTE Study.

Journal: The Journal of clinical endocrinology and metabolism

Published: September 19, 2020

Parietal cell antibodies: evolution of plasma vitamin B12 during oral supplementation to differentiate true and false positives for pernicious anemia.

Journal: Polish archives of internal medicine

Published: July 05, 2020

Oxaliplatin and 5-Fluorouracil in Advanced Well-Differentiated Digestive Neuroendocrine Tumors: A Multicenter National Retrospective Study from the French Group of Endocrine Tumors.

Journal: Neuroendocrinology

Published: May 14, 2020

Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI)-PRODIGE 62: A multicentre, randomised, non-comparative phase II study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: October 04, 2019

Endoscopic management of 345 small rectal neuroendocrine tumours: A national study from the French group of endocrine tumours (GTE).

Journal: United European gastroenterology journal

Published: April 10, 2019

Evaluating bevacizumab in combination with FOLFIRI after the failure of platinum-etoposide regimen in patients with advanced poorly differentiated neuroendocrine carcinoma: The PRODIGE 41-BEVANEC randomized phase II study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: September 21, 2017